Elisabet Selga Coma
Coordinator of the Determinants of Arrhythmogenesis Research Line
Email: elisabet.selga@umedicina.cat
ORCID: 0000-0002-4290-8370
Scientific Profile: URECERCA
Elisabet Selga is an associate professor at the Faculty of Medicine of the Universitat de Vic – Universitat Central de Catalunya.
Dr. Selga is a biologist (2004, UdG) and developed her Ph.D. on the identification of genomic nodes involved in the response to chemotherapeutic treatment with methotrexate (2009, UB). Then she moved to IDIBGI, and under a postdoctoral Sara Borrell fellowship (2012 – 2014), Dr. Selga investigated the pathophysiological effects of genetic variants in cardiac ion channels identified in patients with inherited cardiac disorders and in cases of unexplained sudden death. Her international research stay (2013 – 2014) at the prestigious MRC Centre for Regenerative Medicine in Edinburgh allowed her to implement patient-specific induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) as a cellular model to assess pathophysiological mechanisms and pharmacological responses in patients with Brugada syndrome.
In 2018 she moved to UVic-UCC as professor, and joined IRIS-CC. Since then, her research interests are I) to uncover the cardiac and neurological risk factors that lead to sudden cardiac death, and II) to quantify the impact of a holistic cardiac rehabilitation program on clinical and biochemical biomarkers, on the microbiome and on the mechanisms of atrial inflammation in patients diagnosed with atrial fibrillation and overweight/obesity.
My last happenings:
Maria José Gil’s Commitment to Advancing Wound Care Education
Beyond her research activity within TR2Lab, PhD candidate Maria José Gil has played an active role this year in training healthcare professionals across several educational initiatives in the field of wound care, reaching nurses, nursing residents, and healthcare assistants throughout different regions. FOCUSS Training Programmes (IACS) Maria José coordinated and delivered two continuing professional development programmes promoted by the Aragonese Institute of Health Sciences (IACS), part of the FOCUSS Programme, which offers healthcare professionals practical training placements in reference units. The Advanced Wound Care Techniques programme, delivered in three editions with two registered nurses per edition, combined theoretical and hands-on [...]
Juan Crespo wins Santander X Spain Awards 2026 with the Phygital Bone project
Dr. Juan Crespo, member of the TR2Lab research group, has been named one of the three winners of the Santander X Spain Awards | Proyectos Emprendedores Universitarios 2026, a competition that supports university entrepreneurial talent and showcases innovative projects with social, business, and technological impact. Crespo's winning project, Phygital Bone, is a deep-tech scientific and medical platform focused on severe bone reconstruction. The project combines 3D computational design algorithms, new biomaterials, and bioprinting of personalized implants to address complex bone regeneration challenges. The award was granted following the presentation of eleven finalist projects, held online on June 18th in a [...]
Dr. Anna Fàbrega Presents TR2Lab’s New Research Line on the Microbiome in Complex Wounds
Dr. Anna Fàbrega participated as an invited speaker at the I Jornada Ferides 360: experiència, coneixement i innovació - Parc Sanitari Sant Joan de Déu, where she presented TR2Lab’s new research line focused on the study of the microbiome in complex wounds. During her presentation, she introduced the multicentre project she leads, which aims to longitudinally analyse the intestinal and skin microbiome of patients with diabetic foot ulcers. The study seeks to identify microbial patterns associated with the clinical progression of these lesions, with the goal of improving patient stratification and moving towards a more personalized approach to the management [...]
